Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 9% in First Three Quarters of 2023

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 512 million yuan in the first three quarters of 2023, up 9% year-on-year.

Meanwhile, the company posted 4.9 billion yuan in revenue, up 0.5% year-on-year.

At the end of the reporting period, it had 12.4 billion yuan in total assets and 3.5 billion yuan in total liabilities, with a liability-to-asset ratio of 28.3%.